Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
CAREL Industries Spa's Officer aims to analyze the company's sales strategies, processes, and methodologies.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Francesco Nalini, CAREL Group CEO.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Business of Biotech- Trends in Life Science Funding & Exits|Tim Shannon,General Partner,Canaan Partners
00:10:00
Miles Thompson Highlights Lara Exploration's Key Projects in Brazil and Peru
00:10:00
Medusa Mining Highlights Success and Expansion in Philippine Operations at One-to-One Conference
00:10:00
The video interview with Nico Cacos from Argentina Lithium and Energy Corp.
00:10:00
Interview with Darwin Green, CEO of HighGold: Project Update and Exploration Plans
00:10:00
The Challenge of Cybercrime and Intangible Assets in a Borderless Digital World
00:10:00
Lazard Conférence-Débat avec André Comte-Sponville | Peter Orszag, CEO, Lazard Fr�res Gestion SASAS OF 29 SEP 2023
00:10:00
DOTD CEO Milan Patel and CFO Paraag Amin provide an overview of the company's full-year results for the period ending June 30, 2021, highlighting key operational achievements and financial performance, and outlining future focus areas|Milan Patel, CEO of
00:10:00
Candles Scandinavia CEO Viktor Garmiani Discusses Q1 Performance: Tackling Disruptions and Optimizing Production | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Innovative Weight Management: Exploring Gelesis' Super Absorbent Hydrogel, Plenity
00:10:00
Mag Silver's Presentation Overview: Financial Health, Project Progress, and Exploration Potential
00:10:00
Exploring the Volatility and Potential of the Vanadium Market with Christopher Recklesson